桡骨远端骨巨细胞瘤切除后采用结构性髂骨植骨腕关节融合术的长期结局如何?至少10年随访
该回顾性研究纳入64例桡骨远端Campanacci III级骨巨细胞瘤切除后行腕关节融合与结构性髂骨植骨重建且随访>10年的患者,评估远期功能、并发症及危险因素。5年和10年总体移植物生存率均为98%,10年无翻修生存率76%,84%在12个月内实现骨愈合,35%发生至少一种并发症,28%因重大并发症接受再手术。
要点
- 5年和10年总体移植物生存率均为98%(95%CI 80%至99%)。
- 12个月骨愈合率为84%(54/64),16%(10/64)未愈合。
- 35%(51/144)发生至少一种并发症,28%(41/144)因重大并发症接受再手术。
核心结论
- 桡骨远端骨巨细胞瘤切除后行腕关节融合与结构性髂骨植骨可获得满意的肿瘤学和功能结果。
- 尽管腕关节融合牺牲了腕关节活动度,但在桡骨远端广泛切除后可考虑作为重建选择之一,但无法与其他重建方式比较。
- 功能和并发症需在大样本前瞻性研究中进一步研究。
研究设计与样本
- 回顾性研究,使用北京积水潭医院前瞻性维护的Jishuitan Sarcoma数据库。
- 2005年1月至2025年1月共治疗231例桡骨远端骨巨细胞瘤患者,最终纳入64例随访>10年者进行生存和并发症分析。
- 纳入标准为Campanacci III级骨巨细胞瘤行广泛切除后腕关节融合与结构性髂骨植骨重建且随访至少10年。
- 64例中男性占56%(36/64),平均年龄31±11岁。
主要发现
- 全部144例患者(包括随访>10年和≤10年者)的5年和10年总体移植物生存率均为98%(95%CI 80%至99%)。
- 2年、5年和10年无翻修生存率分别为90%(95%CI 83%至94%)、78%(95%CI 69%至83%)和76%(95%CI 60%至81%)。
- 随访>10年的64例患者中,61%(39/64)在6个月内实现骨愈合,84%(54/64)在12个月内愈合,16%(10/64)未愈合。
- 平均MSTS-93评分为95%±5%(范围0%至100%,评分越高功能越好),平均DASH评分为13±5(范围0至100,评分越低功能越好),平均PRWE评分为18±6(范围0至100,评分越低功能越好)。
- 35%(51/144)患者发生至少一种并发症,28%(41/144)因重大并发症接受51次再手术。
关键数值与推荐
- 主要并发症定义为导致非计划再手术的并发症。
- 移植物生存率采用Kaplan-Meier法计算。
- 功能评估采用MSTS-93、DASH和PRWE评分,腕关节稳定性采用腕骨平移指数,并测量握力。
临床怎么用
- 作者认为,桡骨远端骨巨细胞瘤广泛切除后,腕关节融合与结构性髂骨植骨是可供考虑的重建选择之一,但无法与其他重建方式比较。
- 作者结论指出功能和并发症需在大样本前瞻性研究中进一步研究。
局限性
- 作者指出无法将本重建方式与其他重建选择进行比较。
- 作者指出功能和并发症必须在大样本前瞻性研究中进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Most distal radial giant cell tumors are treated with curettage, whereas malignancies and very advanced giant cell tumor of bone (GCTB) may be treated with resection. Wide resection can achieve good local control, but no consensus has been obtained on the optimal reconstruction method. The use of an endoprosthetic wrist arthroplasty offers the advantage of wrist motion. However, it is associated with a high risk of wrist subluxation, pain, and compensation limitations; ultimately, some patients undergo wrist arthrodesis. We previously reported good early outcomes using wrist arthrodesis and structural iliac bone graft for bone defects after wide resection of the distal radius GCTB. This study evaluates the long-term function, complications, and risk factors of this reconstruction technique at > 10 years of follow-up. QUESTIONS/PURPOSES: (1) What were the 5-year and 10-year overall graft survival and revision-free survival rates? (2) What proportion of patients achieved bone union by 6 and 12 months? (3) What were the functional outcomes of patients at final follow-up? (4) What were the overall proportions of patients who experienced complications and complications leading to reoperation and its possible risk factors? METHODS: After approval by our institutional review board, we performed a retrospective study of patients who underwent wrist arthrodesis and structural iliac bone graft reconstruction after wide resection of distal radius primary bone tumors and who had at least 10 years of follow-up, using our institutional database (Jishuitan Sarcoma database) undergoing prospective maintenance by Beijing Jishuitan Hospital. Between January 2005 and January 2025, we treated 231 patients for distal radius GCTB. Of those, we considered patients with Campanacci III GCTB as potentially eligible. Twenty-three percent (53 of 231) of patients underwent curettage. Based on that, 77% (178 of 231) of patients were eligible. Ten percent (18 of 178) were excluded because they received other reconstruction methods, including vascularized fibular graft and massive allografts. Nine percent (16 of 178) of patients who were lost to follow-up were excluded. Forty-five percent (80 of 178) of patients who had < 10 years of follow-up and 36% (64) of patients were included for survivorship and complication analyses here. Of patients who had > 10 years of follow-up, fifty-six percent (36 of 64) were men. The mean ± SD age was 31 ± 11 years. The indication for reconstruction was resection of Campanacci Grade III GCTB. Patient outcomes included overall graft survival, revision-free survival, functional scores (Musculoskeletal Tumor Society Score-93 [MSTS-93], DASH, and Patient-Rated Wrist Evaluation [PRWE] scores), wrist stability (Carpal Translation Index), and grip strength. All complications were classified as major complications and minor complications. A major complication was defined as a complication resulting in an unplanned reoperation. Graft survival rates were calculated by Kaplan-Meier methods. RESULTS: The 5-year and 10-year overall graft survival rates for all 144 patients (including > 10-year and ≤ 10-year follow-up) were 98% (95% confidence interval [CI] 80% to 99%) and 98% (95% CI 80% to 99%), respectively. The 2-year, 5-year, and 10-year revision-free survival rates were 90% (95% CI 83% to 94%), 78% (95% CI 69% to 83%), and 76% (95% CI 60% to 81%), respectively. For patients who had > 10 years of follow-up, sixty-one percent (39 of 64) of grafts achieved union within 6 months, 84% (54 of 64) united within 12 months, and 16% (10 of 64) did not unite. The mean ± SD MSTS-93 score was 95% ± 5% (range 0% to 100%, with higher scores indicating better function), the mean DASH score was 13 ± 5 (range 0 to 100, with lower scores indicating better function), and the mean PRWE score was 18 ± 6 (range 0 to 100, with lower scores indicating better function). Thirty-five percent (51 of 144) of patients had at least one complication. During follow-up, 28% (41 of 144) of patients underwent 51 reoperations because of major complications. After controlling for potentially confounding variables such as gender, age, and previous surgery, we found that the use of reconstruction plates for fixation (cause-specific HR 2.2 [95% CI 1.3 to 12]; p = 0.02) and bone nonunion (cause-specific HR 2.7 [95% CI 2.1 to 7.2]; p = 0.03) were associated with an increased risk of plate fractures. The use of reconstruction plates (cause-specific HR 2.3 [95% CI 1.4 to 2.9]; p = 0.04) and autograft > 8 cm (cause-specific HR 1.7 [95% CI 1.1 to 3.3]; p = 0.03) was associated with an increased risk of bone nonunion. CONCLUSION: Resection followed by wrist arthrodesis and structural iliac bone graft for distal radius GCTB achieved satisfactory oncologic and functional results, albeit with one-third of all patients experiencing some complications at a minimum of 10 years of follow-up. Although wrist arthrodesis sacrificed wrist mobility, making it an option to consider after extensive resection of the distal radius, we cannot compare this with other reconstruction options. Functional outcomes and complications must be investigated further in large prospective studies. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Li Z, Fan D, Deng Z, et al. What Are the Long-term Outcomes of Wrist Arthrodesis Using Structural Iliac Bone Graft After Resection of the Distal Radius for Giant Cell Tumor of Bone? A Minimum 10-year Follow-up. Clin Orthop Relat Res. 2025. PMID: 41237399. doi:10.1097/CORR.0000000000003738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。